Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic:

Pinak B Shah1, Frederick G P Welt2, Ehtisham Mahmud3

  • 1American College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Insights

This document provides guidelines for triaging patients with structural heart disease during the COVID-19 pandemic. It helps clinicians decide when to proceed with interventions like transcatheter aortic valve replacement despite pandemic risks.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • The COVID-19 pandemic has disrupted healthcare, delaying essential procedures for structural heart disease patients.
  • Delayed interventions increase risks of heart failure (CHF) and mortality in these vulnerable patients.
  • Triage decisions involve balancing procedural risks against the risks of delaying care during the pandemic.

Framework:

  • Presents guidelines for triaging patients requiring structural heart interventions.
  • Offers a decision-making framework for proceeding with interventions amidst the pandemic.
  • Addresses specific interventions such as transcatheter aortic valve replacement and percutaneous mitral valve repair.

Implementation:

  • Focuses on practical considerations for structural heart disease teams.
  • Discusses procedural adaptations and safety measures during the pandemic.
  • Aims to ensure timely and safe patient care in a challenging healthcare environment.

Implications:

  • Facilitates informed decision-making for managing structural heart disease during health crises.
  • Helps mitigate adverse cardiovascular outcomes in patients awaiting procedures.
  • Supports the continued function of specialized heart teams during public health emergencies.

Related Concept Videos